Pill may replace shots for blood cancer patients, study finds

This study tested whether an oral medication (CC-486) could help elderly patients with a serious blood disorder called myelodysplastic syndrome (MDS) maintain their improvement after initial injectable treatment. Eleven patients who had responded to injectable azacitidine switched to the oral form plus standard care. The goal was to see if the oral drug could keep the disease under control and improve quality of life by reducing hospital visits.